We are live on ! Find out more
PCA

Providence Capital Advisors Portfolio holdings

AUM $613M
1-Year Est. Return 17.83%
This Fund
S&P 500
This Quarter Est. Return
-13.31%
1 Year Est. Return
+17.83%
3 Year Est. Return
+42.1%
5 Year Est. Return
+50.05%
10 Year Est. Return
AUM
$344M
AUM Growth
-$64.7M
Cap. Flow
-$7.41M
Cap. Flow %
-2.16%
Top 10 Hldgs %
23.5%
Holding
482
New
11
Increased
70
Reduced
80
Closed
174

Sector Composition

Rank Sector Weight
1 Technology 18.8%
2 Healthcare 13%
3 Financials 10.57%
4 Communication Services 8.99%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRE
476
DELISTED
Duke Realty Corp.
DRE
-42
Closed -$2K
DMRL
477
DELISTED
DeltaShares S&P 500 Managed Risk ETF
DMRL
-125
Closed -$7K
HZNP
478
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-13
Closed -$1K
SIVB
479
DELISTED
SVB Financial Group
SIVB
-4
Closed -$2K
BHVN
480
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-20
Closed -$2K
AZPN
481
DELISTED
ASPEN TECHNOLOGY INC
AZPN
-12
Closed -$2K
HR
482
DELISTED
Healthcare Realty Trust Incorporated
HR
-102,156
Closed -$2.79M

Similar funds

Providence Capital Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Providence Capital Advisors held 482 positions worth $344M, down 16% from $408M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Providence Capital Advisors's Q2 2022 filing shows 11 new, 70 increased, 80 reduced and 174 closed positions. Its largest new stake was Aptiv: 45,637 shares worth $4.07M. The largest sale was Merck, an estimated $4.62M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Providence Capital Advisors's largest Q2 2022 buy was Aptiv: 45,637 shares worth $4.07M.
  • Providence Capital Advisors added most to iShares Core S&P 500 ETF in Q2 2022, an estimated $5.42M increase.
  • Providence Capital Advisors's biggest Q2 2022 reduction was Merck, cutting an estimated $4.62M.
  • Providence Capital Advisors fully exited Innovator US Equity Power Buffer ETF January in Q2 2022, selling an estimated $3.75M.
  • Providence Capital Advisors's ten largest holdings make up 23% of its $344M portfolio in Q2 2022.
  • Providence Capital Advisors opened 11 new positions and closed 174 in Q2 2022.
  • Providence Capital Advisors's portfolio value fell 16% quarter-over-quarter to $344M.

Based on Providence Capital Advisors's 13F filing for Q2 2022, filed 9 Aug 2022.